Johnson & Johnson has launched two new products for astigmatic patients in Europe and the Middle East – ACUVUE OASYS MAX 1-Day Contact Lenses for Astigmatism – the first contact lens to optimise toric design according to cylinder power, and ACUVUE OASYS MAX 1-Day MULTIFOCAL for Astigmatism – the first daily disposable multifocal contact lens for astigmatic presbyopes.

Both contact lenses have been developed with a patient-centric design, enabling eye care professionals to provide more tailored solutions for astigmatic patients.

Supported by ACUVUE’s trusted Eye Inspired Innovations, the lenses offer exceptional comfort, clarity, and stability.

Astigmatism affects about half of patients in at least one eye, making it one of the most common vision conditions.

At the same time, up to 2.1 billion people globally are expected to develop presbyopia by 2030 due to an ageing population. While a variety of contact lens options exist for astigmatic patients, many still face challenges, with one in four discontinuing lens wear in the first year due to issues such as blurred or poor vision and discomfort. These challenges are even more pronounced for patients who develop both astigmatism and presbyopia, where contact lens options remain especially limited.

"We see a clear unmet need in astigmatism and presbyopia across the region, and our goal has been to grow our ACUVUE OASYS MAX 1-Day portfolio to address it. With the launch of these two new toric lenses in the region, we’re proud to offer the first and only complete family of daily disposable contact lenses,” said Jacqueline Henderson, President EMEA, Vision, Johnson & Johnson.

Early clinical data have shown promising fit performance, with 99 percent first lens fit success for ACUVUE OASYS MAX 1-Day for Astigmatism, and 93 percent of wearers successfully fit within two pairs of lenses with ACUVUE OASYS MAX 1-Day MULTIFOCAL for Astigmatism.

"Many of my patients with astigmatism struggle with finding a contact lens that works for them with limited options not addressing their needs – whether they’re looking for a high-performing daily disposable lens for their astigmatism or navigating the added complexity of presbyopia,” said Preete Kumar, Professional Affairs Consultant, Johnson & Johnson.

“These new innovations from ACUVUE offer tailored solutions for both groups, allowing me to meet my patients’ evolving vision needs without compromise. It’s a meaningful step forward in delivering more customised, consistent care,” she added.

ACUVUE OASYS MAX 1-Day for Astigmatism will be available in Italy, the United Kingdom, Ireland, Germany, Austria, Switzerland, France, the Nordics, Poland, Turkey and GCC in 2025.

CUVUE OASYS MAX 1-Day MULTIFOCAL for Astigmatism will be available in Italy, France and the Nordics in 2025.

Both lenses will continue to be rolled out in additional countries in Europe and the Middle East throughout 2026.